Skip to content

NU-MED PLUS, INC.: 10-Q filed 2013-11-14

What NU-MED PLUS, INC. reported in its quarterly report filed 2013-11-14 (fiscal Q3 2013): 27 published measures, 91 facts as tagged in accession 0001548123-13-000455.

This filing

Form
10-Q (quarterly report)
Filed
2013-11-14
Fiscal period
fiscal Q3 2013
Accession
0001548123-13-000455 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NU-MED PLUS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-09-3066,631USD
At 2012-12-31110,403USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-09-30-145,695USD
At 2012-12-31-46,084USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-09-308,339USD
At 2012-12-31731USD
At 2012-09-30185USD
At 2011-12-31870USD
At 2011-10-180USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-142,093USD92
2013-01-01 to 2013-09-30-261,425USD273
2011-10-19 to 2013-09-30-527,810USD713
2012-07-01 to 2012-09-30-110,717USD92
2012-01-01 to 2012-09-30-176,493USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-107,313USD273
2011-10-19 to 2013-09-30-211,774USD713
2012-01-01 to 2012-09-30-74,796USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2013-01-01 to 2013-09-301,679USD273
2011-10-19 to 2013-09-3021,033USD713
2012-01-01 to 2012-09-3018,836USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-07-01 to 2013-09-300USD92
2013-01-01 to 2013-09-300USD273
2011-10-19 to 2013-09-300USD713
2012-07-01 to 2012-09-300USD92
2012-01-01 to 2012-09-300USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-09-30116,600USD273
2011-10-19 to 2013-09-30241,146USD713
2012-01-01 to 2012-09-3092,947USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-1,679USD273
2011-10-19 to 2013-09-30-21,033USD713
2012-01-01 to 2012-09-30-18,836USD274

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2013-07-01 to 2013-09-3027,619,229shares92
2013-01-01 to 2013-09-3027,078,737shares273
2012-07-01 to 2012-09-3026,704,012shares92
2012-01-01 to 2012-09-3021,252,416shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-07-01 to 2013-09-300USD92
2013-01-01 to 2013-09-300USD273
2011-10-19 to 2013-09-300USD713
2012-07-01 to 2012-09-300USD92
2012-01-01 to 2012-09-300USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-09-3017,055USD
At 2012-12-3117,519USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-09-301,765USD273
2011-10-19 to 2013-09-305,112USD713
2012-01-01 to 2012-09-300USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-07-01 to 2013-09-30-87,744USD92
2013-01-01 to 2013-09-30-202,166USD273
2011-10-19 to 2013-09-30-464,034USD713
2012-07-01 to 2012-09-30-110,718USD92
2012-01-01 to 2012-09-30-176,511USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-09-3025,084USD
At 2012-12-3155,833USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2013-07-01 to 2013-09-3054,349USD92
2013-01-01 to 2013-09-3059,259USD273
2011-10-19 to 2013-09-3063,794USD713
2012-07-01 to 2012-09-300USD92
2012-01-01 to 2012-09-300USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2013-09-30212,326USD
At 2012-12-31156,487USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2013-09-305,873USD
At 2012-12-3110,587USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-07-01 to 2013-09-3087,744USD92
2013-01-01 to 2013-09-30202,166USD273
2011-10-19 to 2013-09-30464,034USD713
2012-07-01 to 2012-09-30110,718USD92
2012-01-01 to 2012-09-30176,511USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-09-3029,804,012shares
At 2012-12-3126,804,012shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2013-09-30352,311USD
At 2012-12-31193,497USD
At 2011-12-313,347USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-09-3021,032USD
At 2012-12-3119,354USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2013-09-3015,317USD
At 2012-12-317,400USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-07-01 to 2013-09-304,054USD92
2013-01-01 to 2013-09-3016,277USD273
2011-10-19 to 2013-09-3029,955USD713
2012-07-01 to 2012-09-303,558USD92
2012-01-01 to 2012-09-307,298USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-07-01 to 2013-09-30744USD92
2013-01-01 to 2013-09-302,142USD273
2011-10-19 to 2013-09-303,977USD713
2012-07-01 to 2012-09-30724USD92
2012-01-01 to 2012-09-301,134USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-01-01 to 2013-09-300USD273
2011-10-19 to 2013-09-3086,046USD713
2012-01-01 to 2012-09-3084,647USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-09-30-4,714USD273
2011-10-19 to 2013-09-305,873USD713
2012-01-01 to 2012-09-308,305USD274

Inspect the source

Entity
NU-MED PLUS, INC. / CIK 0001543637
Captured
2026-09-20T09:17:46.167Z
SEC response SHA-256
69b43722f73c0160e01e320460a574e661a132d75253b9bf9ccfdf38c65e1cbf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001543637.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))